Aclarion Announces Agreement with Weill Cornell Medicine

Expands use of Nociscan in groundbreaking trial Broomfield, CO, April 8, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back […]

The post Aclarion Announces Agreement with Weill Cornell Medicine first appeared on Prism Media Wire.